Laxatives (purgatives, aperients) are foods, compounds and/or drugs that facilitate or increase bowel movements. They are most often used to treat constipation. Certain stimulant, lubricant and saline laxatives are used to evacuate the colon for rectal and/or bowel examinations, and may be supplemented by enemas under certain circumstances. Sufficiently high doses of laxatives may cause diarrhea.
- 1 Foods
- 2 Bulk-producing agents
- 3 Stool softeners (surfactants)
- 4 Lubricants or emollient
- 5 Hydrating agents (osmotics)
- 6 Stimulant or irritant
- 7 Serotonin agonist
- 8 Chloride channel activators
- 9 Uses
- 10 Problems with use
- 11 Historical & non-mainstream medical use
- 12 See also
- 13 References
- 14 External links
Foods that help with laxation include fruits, especially banana, kiwifruit and prunes, bran products, aloe vera, blackstrap molasses, pear, and nuts (especially almonds and walnuts).[medical citation needed]
- Site of action: small and large intestine
- Onset of action: 12–72 hours
- Examples: Bran (insoluble fibre), Gum Karaya, Sterculia [Normacol], psyllium husk (Metamucil (soluble fibre)), methylcellulose (Citrucel), polycarbophil, dietary fibre, broccoli, prunes (soluble fibre).
Also known as bulking agents or roughage, these include insoluble dietary fibre. Bulk-producing agents cause the stool to be bulkier and to retain more water, as well as forming an emollient gel, making it easier for peristaltic action to move it along. They should be taken with plenty of water. Bulk-producing agents have the gentlest of effects among laxatives and can be taken just for maintaining regular bowel movements.
Stool softeners (surfactants)
- Site of action: Small and large intestine
- Onset of action: 12–72 hours
- Examples: docusate (Colace, Diocto), Gibs-Eze
Act as a surfactant, enabling additional water and fats to be incorporated in the stool, making it easier to move.
Lubricants or emollient
[See also - Lubricants]
- Site of Action: Colon
- Onset of Action: 6–8 hours
These simply make the stool slippery, so that it slides through the intestine more easily. An example is mineral oil, which also retards colonic absorption of water, softening the stool. Mineral oil may decrease the absorption of fat-soluble vitamins and some minerals.
Hydrating agents (osmotics)
- Site of Action: Small and large intestine
- Onset of Action: 0.5–6 hours
- Examples: sodium phosphate (and variants), potassium sodium tartrate, magnesium citrate, magnesium hydroxide (Milk of magnesia or Cream of magnesia), magnesium sulfate (a.k.a. Epsom salt).
Saline laxatives attract and retain water in the intestinal lumen, thus softening the stool. They also cause the release of cholecystokinin, which stimulates the digestion of fat and protein. Saline laxatives may alter a patient's fluid and electrolyte balance.
- Site of Action: Colon
- Onset of Action: 0.5 hours - 3 days
- Examples: Glycerin suppositories, sorbitol, lactulose, and polyethylene glycol (PEG).
Lactulose works by the osmotic effect, which retains water in the colon, lowering the pH through bacterial fermentation to lactic, formic and acetic acid, and increasing colonic peristalsis. Lactulose is also indicated in Portal-systemic encephalopathy. Glycerin suppositories work mostly by hyperosmotic action, but the sodium stearate in the preparation also causes local irritation to the colon.
Solutions of polyethylene glycol and electrolytes (sodium chloride, sodium bicarbonate, potassium chloride, and sometimes sodium sulfate) are used for whole bowel irrigation, a process designed to prepare the bowel for surgery or colonoscopy and to treat certain types of poisoning. Brand names for these solutions include GoLytely, GlycoLax, CoLyte, Miralax, Movicol, NuLytely, SUPREP, Fortrans, and others. Solutions of sorbitol have similar effects as the aforementioned. Brand name SoftLax.
For adults, a randomized controlled trial found PEG [MiraLax or GlycoLax] 17 grams once per day to be superior to tegaserod at 6 mg twice per day. A randomized controlled trial found greater improvement from 2 sachets (26 grams) of PEG versus 2 sachets (20 grams) of lactulose. 17 grams/day of PEG has been effective and safe in a randomized controlled trial for six months. Another randomized controlled trial found no difference between sorbitol and lactulose.
Stimulant or irritant
Stimulant laxatives (also called "contact laxatives") act on the intestinal mucosa or nerve plexus, altering water and electrolyte secretion. They also stimulate peristaltic action and can be dangerous under certain circumstances. They are the most powerful among laxatives and should be used with care. Prolonged use of stimulant laxatives can create drug dependence by damaging the colon's haustral folds, making a user less able to move feces through the colon on their own. A study of patients with chronic constipation found that 28% of chronic stimulant laxative users lost haustral folds over the course of one year, while none of the control group did.
|Preparation(s)||Type||Site of action||Onset of|
|Cascara (casanthranol)||Anthraquinone||colon||6–8 hours|
|Senna extract (senna glycoside)||Anthraquinone||colon||6–8 hours|
|Aloe vera (aloin)||Anthraquinone||colon||8–10 hours|
|bisacodyl (oral)||Triphenylmethane||colon||6–12 hours|
|bisacodyl (suppository)||Triphenylmethane||colon||60 minutes|
|Microlax||enema||rectum and colon||15–60 minutes|
|Castor oil||ricinoleic acid||small intestine||2–6 hours|
These are motility stimulants that work through activation of 5-HT4 receptors of the enteric nervous system in the gastrointestinal tract. However, some have been discontinued or restricted due to potentially harmful cardiovascular side-effects.
Tegaserod (brand name Zelnorm) was discontinued from marketing in the United States on March 30, 2007. It is still available to physicians for patients in emergency situations that are life-threatening or require hospitalization.
Cisapride (brand name Prepulsid) was voluntarily removed from the U.S. market on July 14, 2000 for the same reason as Tegaserod. Its use in many other countries is discontinued or restricted. It is still available for veterinary use as a compound to treat GI tract problems.
Prucalopride (brand name Resolor) is a current drug approved for use in the EU October 15, 2009 and in Canada (brand name Resotran) on December 7, 2011. It has not been approved by the Food and Drug Administration for use in the United States, but it is in development by Shire PLC.
Chloride channel activators
Lubiprostone (brand name Amitiza) is used in the management of chronic idiopathic constipation and irritable bowel syndrome. It causes the intestines to produce a chloride-rich fluid secretion that softens the stool, increases motility, and promotes spontaneous bowel movements (SBM).
- Bowel preparation
- Chronic constipation
- Chronic immobility
Problems with use
Laxative abuse can lead to potentially fatal fluid and electrolyte imbalances (especially dehydration, hypokalaemia and a metabolic acidosis) as well as intestinal paralysis, irritable bowel syndrome (IBS), pancreatitis, renal failure, factitious diarrhea and other problems.
Although patients with eating disorders such as anorexia nervosa and bulimia nervosa frequently abuse laxatives in an attempt to lose weight, laxatives act to speed up the transit of feces through the large intestine, which occurs subsequent to the absorption of nutrients in the small intestine. Thus, studies of laxative abuse have found that effects on body weight reflect primarily temporary losses of body water rather than energy (calorie) loss 
Physicians warn against the chronic use of stimulant laxatives due to concern that chronic use causes the colonic tissues to get worn out over time and not be able to expel feces due to long-term overstimulation. A common finding in patients having used stimulant laxatives is a brown pigment deposited in the intestinal tissue, known as melanosis coli.
Historical & non-mainstream medical use
Laxatives, then called physicks or purgatives, were used extensively in pre-modern medicine to treat a wide range of conditions for which they are now generally regarded as ineffective in modern evidence-based medicine. Likewise, laxatives (often termed colon cleanses), continue to be promoted by practitioners of complementary medicine for a range of conditions, including conditions that are not medically recognized, e.g. mucoid plaque.
- Das, JL (2010). "Medicinal and nutritional values of banana cv. NENDRAN". Asian Journal of Horticulture 8: 11–14.
- Rush EC, Patel M, Plank LD, Fergus LR (2002). "Kiwifruit promotes laxation in the elderly.". Asia Pac J Clin Nutr 11 (2): 164–8. doi:10.1046/j.1440-6047.2002.00287.x. PMID 12074185.
- Stacewicz-Sapuntzakis, M; Bowen, PE; Hussain, EA; Damayanti-Wood, BI; Farnsworth, NR (2001). "Chemical composition and potential health effects of prunes: a functional food?". Critical reviews in food science and nutrition 41 (4): 251–86. doi:10.1080/20014091091814. PMID 11401245.
- Bulk-forming agent entry in the public domain NCI Dictionary of Cancer Terms
- Di Palma JA, Cleveland MV, McGowan J, Herrera JL (2007). "A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation". Am. J. Gastroenterol. 102 (9): 1964–71. doi:10.1111/j.1572-0241.2007.01365.x. PMID 17573794.
- Attar A, Lémann M, Ferguson A, Halphen M, Boutron M, Flourié B, Alix E, Salmeron M, Guillemot F, Chaussade S, Ménard A, Moreau J, Naudin G, Barthet M (1999). "Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation". Gut 44 (2): 226–30. doi:10.1136/gut.44.2.226. PMC 1727381. PMID 9895382.
- Dipalma JA, Cleveland MV, McGowan J, Herrera JL (2007). "A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation". Am. J. Gastroenterol. 102 (7): 1436–41. doi:10.1111/j.1572-0241.2007.01199.x. PMID 17403074.
- Lederle F, Busch D, Mattox K, West M, Aske D (1990). "Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose". Am J Med 89 (5): 597–601. doi:10.1016/0002-9343(90)90177-F. PMID 2122724.
- "BestBETs: Is polyethylene glycol safe and effective for chro...". Retrieved 2007-09-06.
- Laxative (Oral Route) from Mayo clinic. Last updated: Nov. 1, 2012
- Joo J, Ehrenpreis E, Gonzalez L, Kaye M, Breno S, Wexner S, Zaitman D, Secrest K (1998). "Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited". J Clin Gastroenterol 26 (4): 283–6. doi:10.1097/00004836-199806000-00014. PMID 9649012.
- Alterations in Colonic Anatomy Induced by Chronic Stimulant Laxatives: The Cathartic Colon Revisited Joo et al. Journal of Clinical Gastroenterology. June 1998 Volume 26 Issue 4 pp 283 - 286. http://journals.lww.com/jcge/Abstract/1998/06000/Alterations_in_Colonic_Anatomy_Induced_by_Chronic.14.aspx
- Dharmananda, Subhuti. "SAFETY ISSUES AFFECTING HERBS: How Long can Stimulant Laxatives be Used?". Institute for Traditional Medicine. Retrieved 2010-03-19.
- "Stimulant Laxatives". Family Practice Notebook, LLC. 2010-02-26. Retrieved 2010-03-19.
- Tegaserod, FDA Zelnorm (tegaserod maleate) Information
- European Medicines Agency EPAR summary for the public
- Health Canada, Notice of Decision for Resotran
- http://www.shire.com/shireplc/en/rd/pipeline Shire PLC, R and D projects, Resolor
- "Laxative Abuse: Some Basic Facts" (PDF). National Eating Disorders Association. 2005. Retrieved 2008-09-07.
- Brown, N. W.; Treasure, J. L.; Campbell, I. C. (2001). "Evidence for long-term pancreatic damage caused by laxative abuse in subjects recovered from anorexia nervosa". International Journal of Eating Disorders 29 (2): 236–238. doi:10.1002/1098-108X(200103)29:2<236::AID-EAT1014>3.0.CO;2-G. PMID 11429987.
- Copeland P; Molina, H.; Ohye, Ch.; MacIas, R.; Alaminos, A.; Alvarez, L.; Teijeiro, J.; Muñoz, J.; Ortega, I. (1994). "Renal failure associated with laxative abuse". Psychother Psychosom 62 (3–4): 200–2. doi:10.1159/000098619. PMID 7531354.
- Wright L, DuVal J (1987). "Renal injury associated with laxative abuse". South Med J 80 (10): 1304–6. doi:10.1097/00007611-198710000-00024. PMID 3660046.
- Oster JR, Materson BJ, Rogers AI (November 1980). "Laxative abuse syndrome". Am. J. Gastroenterol. 74 (5): 451–8. PMID 7234824.
- Lacey, J. H.; Gibson, E. (1985). "Controlling weight by purgation and vomiting: A comparative study of bulimics". Journal of psychiatric research 19 (2–3): 337–341. doi:10.1016/0022-3956(85)90037-8. PMID 3862833.
- Joo JS, Ehrenpreis ED, Gonzalez L, et al. (June 1998). "Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited". Journal of Clinical Gastroenterology 26 (4): 283–6. doi:10.1097/00004836-199806000-00014. PMID 9649012.
|Wikimedia Commons has media related to Laxatives.|